Updates are available Correction dated 2023-04-11
Click to view Correction: https://doi.org/10.1038/s44161-023-00269-z
-
Authors
Knight-Schrijver, Vincent R. https://orcid.org/0000-0002-7916-3827
Davaapil, Hongorzul
Bayraktar, Semih
Ross, Alexander D. B.
Kanemaru, Kazumasa
Cranley, James
Dabrowska, Monika
Patel, Minal
Polanski, Krzysztof
He, Xiaoling
Vallier, Ludovic
Teichmann, Sarah
Gambardella, Laure https://orcid.org/0000-0001-5771-1565
Sinha, Sanjay https://orcid.org/0000-0001-5900-1209
-
Funding
Funding for this research was provided by:
BHF Centre of Research Excellence, Oxford (RM/17/2/33380)
Wellcome Trust (203151/Z/16/Z, 203151/Z/16/Z, 203151/Z/16/Z, 203151/Z/16/Z, 203151/Z/16/Z, WT206194, 203151/Z/16/Z)
British Heart Foundation (RG/17/5/32936, FS/18/46/33663, PG/17/24/32886, FS/18/46/33663)
Takeda Science Foundation
Wellcome Trust Clinical PhD Fellowship
Wellcome Trust (203151/Z/16/Z)
- License Information
-
More Information
Article History
Received: 14 October 2021
Accepted: 3 November 2022
First Online: 21 December 2022
Change Date: 11 April 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s44161-023-00269-z
Competing interests
: In the past 3 years, S.A.T. has consulted or been a member of scientific advisory boards at Roche, Genentech, Biogen, GlaxoSmithKline, Qiagen and ForeSite Labs and is an equity holder of Transition Bio. All other authors declare no competing interests.
